Compare · MDLN vs SNWV
MDLN vs SNWV
Side-by-side comparison of Medline Inc. (MDLN) and SANUWAVE Health Inc. (SNWV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SNWV operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 1166.4x SNWV ($40.2M).
- MDLN has been more active in the news (12 items in the past 4 weeks vs 3 for SNWV).
- MDLN has more recent analyst coverage (25 ratings vs 2 for SNWV).
- Company
- Medline Inc.
- SANUWAVE Health Inc.
- Price
- $35.64+2.77%
- $4.69-1.47%
- Market cap
- $46.86B
- $40.2M
- 1M return
- -10.28%
- -
- 1Y return
- -12.54%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 12
- 3
- Recent ratings
- 25
- 2
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest SNWV
- SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Sanuwave Announces Q2 FY2026 Financial Results
- SEC Form 10-Q filed by SANUWAVE Health Inc.
- Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
- SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
- SEC Form 4 filed by Director Blizard Jeffrey
- SEC Form 4 filed by Director Miller Ian D.
- SEC Form 4 filed by Director Bazar Gregory Matthew
- SEC Form 4 filed by Director Tyler James